Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ANIP
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Stephen Carey Officer | ANIP ANI Pharmaceuticals, Inc. | 8,550 | $613.1K | 10b5-1 | Oct 29, 2026 | Form 4 ↗ 1 day later · 2,850 shares | Form 144 ↗ |
| Oct 15, 2026 | Nikhil Lalwani Director, Officer | ANIP ANI Pharmaceuticals, Inc. | 5,400 | $378.9K | 10b5-1 | Oct 15, 2026 | Form 4 ↗ 1 day later · 5,400 shares | Form 144 ↗ |
| Sep 15, 2026 | Nikhil Lalwani Director, Officer | ANIP ANI Pharmaceuticals, Inc. | 5,400 | $380.2K | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 1 day later · 5,400 shares | Form 144 ↗ |
| Sep 11, 2026 | Jeanne Thoma Director | ANIP ANI Pharmaceuticals, Inc. | 1,000 | $71.5K | 10b5-1 | Sep 11, 2026 | Form 4 ↗ 3 days later · 1,000 shares | Form 144 ↗ |
| Aug 25, 2026 | Nikhil Lalwani Director, Officer | ANIP ANI Pharmaceuticals, Inc. | 5,400 | $400.5K | 10b5-1 | Aug 25, 2026 | Form 4 ↗ 1 day later · 5,400 shares | Form 144 ↗ |
| Jul 29, 2026 | Stephen P Carey Officer | ANIP ANI Pharmaceuticals, Inc. | 6,163 | $499.4K | 10b5-1 | Jul 29, 2026 | Form 4 ↗ 1 day later · 2,850 shares | Form 144 ↗ |
| Jul 7, 2026 | Patrick Walsh Director | ANIP ANI Pharmaceuticals, Inc. | 4,336 | $373.7K | — | Jul 7, 2026 | — | Form 144 ↗ |
| Jun 8, 2026 | Thomas Haughey Director | ANIP ANI Pharmaceuticals, Inc. | 2,000 | $162.2K | 10b5-1 | Jun 8, 2026 | Form 4 ↗ 2 days later · 2,000 shares | Form 144 ↗ |
| Jun 5, 2026 | Stephen P Carey Officer | ANIP ANI Pharmaceuticals, Inc. | 11,862 | $939.5K | 10b5-1 | Jun 5, 2026 | Form 4 ↗ 4 days later · 3,312 shares | Form 144 ↗ |
| May 13, 2026 | Patrick D. Walsh Director | ANIP ANI Pharmaceuticals, Inc. | 10,000 | $795.6K | — | May 13, 2026 | Form 4 ↗ same day · 13,973 shares | Form 144 ↗ |
| May 11, 2026 | Nikhil Lalwani Officer, Director | ANIP ANI Pharmaceuticals, Inc. | 55,000 | $4.3M | — | May 11, 2026 | Form 4 ↗ 2 days later · 55,000 shares | Form 144 ↗ |
| May 11, 2026 | Patrick Walsh Director | ANIP ANI Pharmaceuticals, Inc. | 3,973 | $320.8K | — | May 11, 2026 | Form 4 ↗ 2 days later · 13,973 shares | Form 144 ↗ |
| Mar 5, 2026 | Stephen P Carey Officer | ANIP ANI Pharmaceuticals, Inc. | 7,312 | $552.0K | — | Mar 5, 2026 | Form 4 ↗ same day · 7,312 shares | Form 144 ↗ |
| Mar 3, 2026 | Patrick Walsh Director | ANIP ANI Pharmaceuticals, Inc. | 6,000 | $445.4K | — | Mar 3, 2026 | Form 4 ↗ same day · 6,000 shares | Form 144 ↗ |
| Dec 9, 2025 | Renate Plawner Tannenbaum 2024 RV Trust Director | ANIP ANI Pharmaceuticals, Inc. | 1,800 | $146.1K | — | Dec 5, 2025 | — | Form 144 ↗ |
| Nov 13, 2025 | Patrick Walsh Director | ANIP ANI Pharmaceuticals, Inc. | 8,643 | $750.9K | — | Nov 13, 2025 | Form 4 ↗ 4 days later · 8,643 shares | Form 144 ↗ |
| Sep 3, 2025 | Antonio R Pera Director | ANIP ANI Pharmaceuticals, Inc. | 7,292 | $692.3K | — | Sep 3, 2025 | Form 4 ↗ 1 day later · 7,292 shares | Form 144 ↗ |
| Aug 25, 2025 | Matthew Leonard Director | ANIP ANI Pharmaceuticals, Inc. | 2,528 | $229.1K | — | Aug 25, 2025 | Form 4 ↗ 1 day later · 2,528 shares | Form 144 ↗ |
| Aug 21, 2025 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 52,988 | $4.8M | — | Aug 21, 2025 | Form 4 ↗ 1 day later · 100,000 shares | Form 144 ↗ |
| Aug 20, 2025 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 47,012 | $4.2M | — | Aug 20, 2025 | Form 4 ↗ 2 days later · 100,000 shares | Form 144 ↗ |
| Aug 20, 2025 | Antonio R Pera Director | ANIP ANI Pharmaceuticals, Inc. | 5,421 | $486.4K | — | Aug 20, 2025 | Form 4 ↗ same day · 5,421 shares | Form 144 ↗ |
| Aug 19, 2025 | Jeanne Thoma Director, 10% Stockholder | ANIP ANI Pharmaceuticals, Inc. | 14,675 | $1.3M | — | Aug 18, 2025 | Form 4 ↗ 1 day later · 21,540 shares | Form 144 ↗ |
| Aug 18, 2025 | Jeanne A Thoma Director | ANIP ANI Pharmaceuticals, Inc. | 6,865 | $616.2K | — | Aug 18, 2025 | Form 4 ↗ 2 days later · 21,540 shares | Form 144 ↗ |
| Aug 18, 2025 | Matthew Leonard Director | ANIP ANI Pharmaceuticals, Inc. | 6,937 | $611.6K | — | Aug 18, 2025 | Form 4 ↗ same day · 6,937 shares | Form 144 ↗ |
| Aug 18, 2025 | Ampersand 2020 Limited Partnership Director | ANIP ANI Pharmaceuticals, Inc. | 29,580 | $2.6M | — | Aug 18, 2025 | — | Form 144 ↗ |
| Aug 15, 2025 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 52,990 | $4.6M | — | Aug 15, 2025 | Form 4 ↗ 3 days later · 100,000 shares | Form 144 ↗ |
| Aug 15, 2025 | Patrick Walsh Director | ANIP ANI Pharmaceuticals, Inc. | 9,000 | $801.5K | — | Aug 15, 2025 | Form 4 ↗ 3 days later · 9,000 shares | Form 144 ↗ |
| Aug 15, 2025 | Ampersand 2020 Limited Partnership Director | ANIP ANI Pharmaceuticals, Inc. | 91,000 | $7.9M | — | Aug 15, 2025 | — | Form 144 ↗ |
| Aug 14, 2025 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 47,010 | $4.2M | — | Aug 14, 2025 | Form 4 ↗ 4 days later · 100,000 shares | Form 144 ↗ |
| Aug 12, 2025 | Nikhil S Lalwani Officer, Director | ANIP ANI Pharmaceuticals, Inc. | 56,960 | $4.9M | — | Aug 12, 2025 | Form 4 ↗ 2 days later · 56,960 shares | Form 144 ↗ |
| Aug 12, 2025 | Thomas Haughey Director | ANIP ANI Pharmaceuticals, Inc. | 19,341 | $1.7M | — | Aug 12, 2025 | Form 4 ↗ 2 days later · 19,341 shares | Form 144 ↗ |
| Aug 12, 2025 | Stephen P Carey Officer | ANIP ANI Pharmaceuticals, Inc. | 50,000 | $4.3M | — | Aug 12, 2025 | Form 4 ↗ 2 days later · 50,000 shares | Form 144 ↗ |
| May 12, 2025 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 700 | $53.7K | 10b5-1 | May 9, 2025 | Form 4 ↗ 1 day later · 700 shares | Form 144 ↗ |
| Dec 17, 2024 | Stephen P. Carey Officer | ANIP ANI Pharmaceuticals, Inc. | 7,500 | $414.4K | — | Dec 17, 2024 | Form 4 ↗ 1 day later · 7,500 shares | Form 144 ↗ |
| Nov 26, 2024 | Lalwani Nikhil Officer | ANIP ANI Pharmaceuticals, Inc. | 33,481 | $1.9M | — | Nov 26, 2024 | Form 4 ↗ 1 day later · 33,481 shares | Form 144 ↗ |
| Jul 18, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 2,743 | $170.1K | 10b5-1 | Jul 18, 2024 | — | Form 144 ↗ |
| Jul 17, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 14,257 | $900.5K | 10b5-1 | Jul 17, 2024 | — | Form 144 ↗ |
| Jul 16, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 22,000 | $1.4M | 10b5-1 | Jul 16, 2024 | — | Form 144 ↗ |
| Jul 15, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 11,000 | $697.2K | 10b5-1 | Jul 15, 2024 | — | Form 144 ↗ |
| Jun 21, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 20,000 | $1.2M | 10b5-1 | Jun 21, 2024 | — | Form 144 ↗ |
| Jun 20, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 11,447 | $685.2K | 10b5-1 | Jun 20, 2024 | — | Form 144 ↗ |
| Jun 18, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 10,607 | $644.4K | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 17, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 7,946 | $488.0K | 10b5-1 | Jun 17, 2024 | — | Form 144 ↗ |
| Jun 4, 2024 | Stephen P. Carey Officer | ANIP ANI Pharmaceuticals, Inc. | 5,000 | $310.0K | — | Jun 4, 2024 | — | Form 144 ↗ |
| May 20, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 12,855 | $794.6K | 10b5-1 | May 20, 2024 | — | Form 144 ↗ |
| May 17, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 5,836 | $362.4K | 10b5-1 | May 17, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 16,459 | $1.1M | 10b5-1 | May 16, 2024 | — | Form 144 ↗ |
| May 16, 2024 | Renate Tannenbaum board member | ANIP ANI Pharmaceuticals, Inc. | 2,000 | $127.7K | — | May 16, 2024 | — | Form 144 ↗ |
| May 15, 2024 | Shanmugam Muthusamy Officer | ANIP ANI Pharmaceuticals, Inc. | 14,850 | $978.0K | 10b5-1 | May 15, 2024 | — | Form 144 ↗ |
| May 14, 2024 | Lalwani Nikhil Officer | ANIP ANI Pharmaceuticals, Inc. | 16,669 | $1.1M | — | May 14, 2024 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:51 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances